Momenta Pharmaceuticals, Inc. (MNTA)

[io_io]

What is your point? ..... I guess you like to ignore Rader's dissent

Polly, you will remember that years ago I gave you solid advice on IDIX in similar circumstances. I would answer both your statements by pointing to this post.

By the way, as a word of warning, I think you are being pumped by this other post here.

I mean, how on the one hand can MNTA holders expect, in the mCop case, to overturn a process patent that has already been validated by the courts, while in the mLov case, expect to prevail on a process patent that has already been rejected by the courts?